Pura Vida Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-69,750
Closed -$13.3M 140
2019
Q4
$13.3M Buy
69,750
+2,641
+4% +$476K 1.17% 27
2019
Q3
$11.3M Buy
67,109
+20,000
+42% +$3.26M 1.93% 21
2019
Q2
$7.89M Buy
47,109
+4,984
+12% +$690K 1.2% 25
2019
Q1
$6.17M Buy
42,125
+22,125
+111% +$3.21M 0.88% 34
2018
Q4
$2.67M Buy
+20,000
New +$3.28M 0.53% 37
2018
Q3
Sell
-20,000
Closed -$3.33M 150
2018
Q2
$3.33M Buy
20,000
+10,000
+100% +$1.61M 1.34% 23
2018
Q1
$1.68M Buy
+10,000
New +$1.68M 0.99% 33
2017
Q4
Sell
-35,000
Closed -$7.17M 110
2017
Q3
$7.17M Buy
+35,000
New +$8.14M 2.1% 14
2017
Q2
Sell
-28,875
Closed -$6.9M 106
2017
Q1
$6.9M Buy
28,875
+22,175
+331% +$5.16M 2.04% 18
2016
Q4
$1.41M Sell
6,700
-4,050
-38% -$839K 0.52% 48
2016
Q3
$2.48M Buy
10,750
+2,830
+36% +$692K 0.75% 54
2016
Q2
$1.83M Sell
7,920
-34,580
-81% -$7.97M 0.78% 50
2016
Q1
$11.4M Buy
42,500
+29,900
+237% +$8.56M 5.18% 2
2015
Q4
$3.94M Buy
12,600
+5,600
+80% +$1.67M 1.66% 27
2015
Q3
$1.9M Buy
+7,000
New +$2.15M 1.09% 40
2015
Q2
Sell
-10,875
Closed -$3.24M 88
2015
Q1
$3.24M Buy
10,875
+7,450
+218% +$2.12M 1.67% 24
2014
Q4
$882K Buy
+3,425
New +$856K 0.32% 61

Other funds holding AGN

Pura Vida Investments's AGN Position: Q1 2020 in Review

Pura Vida Investments sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 69,750 shares — an estimated $13.3M sold.

Pura Vida Investments first reported a position in AGN in Q4 2014 and held it in 17 quarters. The position peaked at $13.3M in Q4 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Pura Vida Investments reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Pura Vida Investments sold 69,750 Allergan plc shares in Q1 2020, an estimated $13.3M.
  • Pura Vida Investments first reported a position in Allergan plc in Q4 2014 and held it in 17 quarters.
  • Pura Vida Investments's Allergan plc position peaked at $13.3M in Q4 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Pura Vida Investments's 13F filing for Q1 2020, filed 15 May 2020.